Martin Daniel C.

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 48% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Martin Daniel C.'s trades of Deciphera Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-02-20 2024-02-16
S Sale
53,714 -4.4%
164.26
US$2,653,437 		53,714 -4.4% 164.26 US$2,653,437
2024-01-18 2024-01-16
S Sale
32,948 +29.5%
282.59
US$1,345,624 		32,948 +29.5% 282.59 US$1,345,624
2023-12-14 2023-12-13
S Sale
75,310 +34.9%
485.18
US$2,708,830 		75,310 +34.9% 485.18 US$2,708,830
2023-12-01 2023-11-30
PlS Planned sale
17,801 -28.2%
12.57
US$223,755 		17,801 -28.2% 12.57 US$223,755
2023-11-30 2023-11-30
PrS Proposed sale
17,801
12.57
US$223,755 		17,801 12.57 US$223,755
2023-10-31 2023-10-30
S Sale
1,407 -2.2%
12.02
US$16,909 		1,407 -2.2% 12.02 US$16,909
2023-06-21 2023-06-16
PlS Planned sale
1,238 -2.1%
14.40
US$17,829 		1,238 -2.1% 14.40 US$17,829
2023-02-17 2023-02-16
S Sale
1,159 -1.9%
15.10
US$17,500 		1,159 -1.9% 15.10 US$17,500
2023-01-19 2023-01-17
PlS Planned sale
1,603 -3.2%
21.24
US$34,050 		1,603 -3.2% 21.24 US$34,050
2022-06-21 2022-06-16
PlS Planned sale
1,311 -2.6%
10.75
US$14,093 		1,311 -2.6% 10.75 US$14,093
2022-02-18 2022-02-16
S Sale
1,146 -2.3%
9.05
US$10,371 		1,146 -2.3% 9.05 US$10,371
2020-01-24 2020-01-22
PlS Planned sale
26,999 -61.4%
67.18
US$1,813,709 		26,999 -61.4% 67.18 US$1,813,709
2019-09-23 2019-09-19
PlS Planned sale
3,000 -15.0%
35.56
US$106,688 		3,000 -15.0% 35.56 US$106,688